NALFD (non-alcoholic fatty liver disease) represents a fatty liver whereby lipid accumulation (steatosis) occurs. In recent decades, the prevalence of NAFLD has dramatically increased.
Introduction
NAFLD is characterized by a fatty liver or hepatic steatosis, whereby the hepatic fat percentage exceeds 5% of the wet weight of the liver [1] . This hepatic steatosis results from an imbalance between lipid availability and lipid release. Simple steatosis is a relatively early, non-risky stage, since no inflammation is present in the liver [2] . NAFLD can however progress in nonalcoholic steatohepatitis (NASH), a more detrimental and advanced stage of fatty liver disease, characterized by hepatic inflammation. Patients with NASH can develop hepatic fibrosis, cirrhosis and finally hepatocellular carcinoma, which will lead to increased mortality [3] .
The hepatic lipid metabolism is altered in patients with NAFLD. It seems that high hepatic lipid content and insulin resistance are also associated with alterations of proteins and enzymes involved in lipid metabolism of adipose tissue [4] . A well-known fact is the increase in the rate of adipose tissue lipolysis in subjects with NAFLD [5] . From previous data is known that mice fed a HFD exhibit adipose tissue dysfunction, characterized by down-or upregulation of several genes involved in lipid metabolism of adipose tissue [6] .
In the previous section, it is explained that NAFLD is often associated with alterations in the lipid metabolism of liver and adipose tissue. There seems to be a crosstalk between the immune system and adipose tissue. Obesity is related to adipose dysfunction and represents a state of chronic low-grade inflammation. It is believed that infiltration of macrophages in liver or adipose tissue contributes to the development of NAFLD and induces the production of reactive oxidative species (ROS). ROS will result in higher oxidative stress, which contributes to the progression of NAFLD [7] . The inflammatory response present in NASH is activated by the innate immune system [8] . The complement system is a subset of the innate immune system [9] . Preliminary data suggest that complement activation may have a significant role in the pathogenesis and progression of NAFLD and NASH [3, 8] . Complement activation occurs through three pathways, the classical, alternative and mannose binding lectin pathway. Activation of these pathways depends on different molecules for their initiation and amplification [10] . These three pathways will, however, converge at the central component C3, which is the most important and abundant component in the complement system. The cleavage product of C3 is C3a. C3a can influence, via activation of nuclear factors and cytokines, the process of liver regeneration. Deficiency of C3a diminishes liver regeneration [10] . C3a, however, also stimulates the production of prostanoids and pro-inflammatory cytokines by Kupffer cells thereby contributing to a pro-inflammatory environment [11] .
The complement system has, next to its part in innate immunity, as described above, also a role in the lipid metabolism of adipose tissue. The protein ASP exerts an important function herein. C3a is rapidly converted, by plasma carboxypeptidase N or R, to acylationstimulating protein (ASP). ASP, also referred to as C3adesArg, is the biologically inactive fragment of C3a [12] . Both in human and mice, levels of ASP are elevated in obese subjects, diabetics, and associated metabolic disorders. ASP levels are decreased upon weight loss or exercise [13] . Thus, it is believed that both ASP and its precursor C3a have an important role in the regulation of fatty acid uptake in adipose tissue and body lipid homeostasis [11] , and these processes show a connection between the alternative complement pathway and metabolism of the adipose tissue [12] .
It seems that both complement factor C3 and ASP may have a great influence on both the development of NAFLD and lipid metabolism in liver and adipose tissue. In this study, it will be investigated whether C3 affects hepatic steatosis in mice. Also, the potential inhibitory and stimulating effects of ASP on genes involved in lipid metabolism in adipose will be studied.
The aims of this study were firstly, to determine if preliminary data, which suggested that complement factor C3 deficiency diminishes steatosis in NASH, corresponds with own found results in this study. Secondly, to examine if the expression of candidate genes involved in the lipid metabolism of adipose tissue are altered in C3 wild type and knock out mice. Evaluation of histological stainings by an experienced liver pathologist revealed that wild type mice had higher NASH grades compared to C3 knockout mice. Mice fed the HFD appeared to have more hepatic lipid accumulation compared to mice that received the chow diet. Thus, it is expected that C3 wild type mice receiving the HFD diet will have the highest hepatic lipid accumulation.
Material and methods
Twelve-weeks-old specific pathogen-free male C57BL/6 (C3 
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In this study, liver and adipose tissue from wild-type mice (C3
is used to examine the research question. The control group of this study consisted of C3 +/+ mice (n=6) and C3 -/-mice (n=6), which were fed a standard chow diet for 12 weeks.
The experimental group consisted of C3 +/+ mice (n=11) and C3 -/-mice (n=11), which were fed a high fat diet (HFD) (D12492, Research Diets) for 12 weeks, to examine the effect of a mild NAFLD inducing diet on complement activation. Mice from the control and experimental group were littermates. All mice had ad libitum access to food and water.
The HFD contained 60% energy as triglycerides. Mice were sacrificed by CO2 asphyxiation.
Snap frozen liver and adipose tissue was used for histological staining and RNA isolation, respectively.
Hepatic lipid accumulation of each mouse was determined by Oil Red O staining. Deepfrozen liver pieces were cut in 4 µm thick liver sections using a cryostat and subsequently stained. The liver morphology was evaluated using a light microscope. Lipid accumulation was scored on a 0-3 point scale resulting in 4 groups. The sections were scored taking into account the size and intensity of the red colour, which represents lipid droplets. It was also checked if the droplets were evenly distributed over the tissue.
RNA from adipose tissue was isolated and used to synthesize cDNA according to the protocols. The produced cDNA was used as a template for the quantitative polymerase chain reactions (qPCR). Primers of several enzymes, involved in the lipid metabolism of adipose tissue, were used. Eventually the relative gene expression of these enzymes was calculated according to the delta-Ct relative quantification method.
Results

Body weight gain and liver weight in C3 +/+ and C3 -/-mice fed a HFD or chow diet
To study the effect of C3 activation on hepatic steatosis, two mice groups, a wild-type Additional preliminary data also showed the hepatic effect of the diets. Liver weight as percentage of body weight was significantly higher in C3 +/+ and C3 -/-fed a chow diet (Fig. 2 , Table 2 , 4,53 ± 0,27; 4,12 ± 0,13, respectively) compared to mice fed a HFD (3,79 ± 0,67; 3,40 ± 213 0,36, respectively) (p=0,0001). The liver weight also differed significantly between the two mice groups (p=0,0216). In table 2 an overall summary of body parameters of C3 +/+ and C3 -/-mice is given. 
C3 -/-mice fed a HFD or chow diet
To understand the involvement of the lipid metabolism of adipose tissue in the development of NASH, the expression of several genes involved in fatty acid synthesis, degradation and development, was examined in relation to hepatic steatosis in mice.
Messenger RNA (mRNA) expression of some adipose tissue enzymes involved in lipid metabolism was significantly different between the genotype of mice and between the diets the mice received.
The expression of the enzymes FASN and SCD1, important for lipid synthesis, was significantly higher in the chow diet group compared to the HFD in both mice genotypes for FASN and in the C3 -/-mice group for SCD1 (Fig. 4, p<0 ,0001 and p=0,0024, respectively).
The expression of the adipogenic gene PPARγ was significantly higher in the HFD compared to the chow diet in the C3 +/+ mice group (Fig. 4, p=0, 
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The expression level of the enzyme DGAT1, also involved in lipid synthesis differed significantly between both mouse groups and was, in the C3 +/+ mice group, significantly higher in the chow diet group compared to the HFD (Fig. 5, p=0 ,0024 and p=0,0094, respectively). For the enzyme HSL, involved in adipose lipolysis, the expression was significantly different between the two mouse groups (Fig. 5, p=0,0138 
Discussion/Conclusion
In the present study, C57Bl/6 mice fed a HFD, were used as representative animal model for human hepatic steatosis. To examine the influence of complement factor C3 on hepatic lipid accumulation and genes involved in lipid metabolism of adipose tissue, C3 knock out and C3 wild type mice were used. Thus the data obtained during this research demonstrate the different effects of a HFD and chow diet on the presence of steatosis and alterations in genes involved in lipid metabolism of adipose tissue, in C3 +/+ and C3 -/-mice. As expected high fat feeding resulted in higher weight gain in mice compared to chow fed mice (Fig 1.) .
Histological stainings and steatosis scoring
Taking into account the scores of hepatic lipid accumulation after ORO staining, C3 -/-mice did not have significantly lower mean scores for both diets compared to C3 +/+ mice. This finding is in contrast with the hypothesis and earlier found results, which stated that mice deficient in C3 have significantly lower steatosis scores in NASH [11] . From the results can be derived that there is no significantly difference in steatosis scores between the HFD and chow diet. There is, however, a trend visible towards higher steatosis scores in the HFD groups ( Table 2) . From the histological staining images can be seen that both mice groups on the HFD have the highest accumulation of lipids in their liver, which corresponds with preliminary steatosis scores in NASH. From the images can be concluded that the HFD indeed triggers mild steatosis in the liver.
Because there is also lipid accumulation present in C3 -/-mice on a HFD, it appears that lipids can also accumulate in the liver without C3 activation. The complement system has both 219 detrimental and beneficial effects in the liver. On the one hand activation of complement results in inflammation and tissue damage, on the other hand it is involved in the cleanup process of dead cells. In C3 -/-mice, the protective function of the complement system may be absent, which could contribute to hepatic lipid accumulation in C3 -/-mice fed a HFD [11] . In addition, C3 activation normally results in the formation of C3a, which is converted to ASP. This protein clears postprandial triglycerides and promotes the uptake of FFA to peripheral fat tissue. Research states that disturbances in the ASP pathway will result in hypertriglyceridemia and an increased flux of FFAs to the liver, leading to hepatic steatosis [2] .
mRNA expression levels of lipid genes in adipose tissue
There exists a relation between C3 activation and lipid metabolism. Two pathways play a role herein. Firstly, the expression of the C3a receptor (C3aR) is very high in white adipose tissue and up regulated after a HFD. In mice deficient in this C3aR, no insulin resistance occurs [14] . Secondly, also in C5a-like receptor 2 (C5L2) knockout mice, multiple metabolic effects are present, such as reduced triacylglycerol synthesis in adipose tissue and delayed clearance of triacylglycerol and glucose. ASP resistance, due to impaired signalling of ASP via C5L2, plays an important role in the altered lipid metabolism in adipose tissue [14] . ASP deficient mice are resistant to diet-induced obesity and insulin resistance, and have decreased adipose tissue depots [2, 15] . This is also observed in figure 1 , where the C3 -/-mice exhibit lower weight gain in both the HFD and chow diet group compared to the C3 +/+ mice.
In this study, mRNA expression of several enzymes involved in lipid metabolism was examined to investigate a possible link between altered lipid metabolism in adipose tissue and C3/ASP deficiency. Expression levels of FASN were significantly higher in both mice groups, and expression of SCD1 was significantly higher in C3 -/-mice, fed a chow diet compared to mice fed a HFD. These results do not correspond to the stated hypothesis, which expected that expression of FASN and SCD1 would be higher in high fat feeding mice, due to the stimulating effect on lipogenesis by ASP. The expression of PPARγ was significantly higher in the C3 +/+ mice that received a HFD in contrast to the chow diet. 
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However, other literature describes that subjects with NAFLD have higher adipose tissue lipolysis rate [5] . This effect is contradictory to the inhibitory effect of ASP on HSL. Our data show that adipose tissue expression of HSL is significantly higher in the C3 +/+ mice group compared to the C3 -/-mice group. This corresponds with the earlier stated hypothesis, which expected an increased expression of enzymes involved in lipolysis such as HSL. The expression of the enzyme DGAT1 is higher in mice that received the chow diet compared to mice that received the HFD, this is not in agreement with the hypothesis, which expected higher expression of lipogenic genes in C3 +/+ mice fed a HFD.
Since the expression of HSL is higher in C3 +/+ mice instead of C3 -/-mice, the inhibitory effect of ASP on HSL is exceeded by the higher lipolysis rate present in C3 +/+ mice with NAFLD.
Because the expression of HSL and DGAT1 is higher in adipose tissue of C3 +/+ mice, there will be an elevated flux of fatty acids to the bloodstream and eventually the liver, as depicted in the figure below (Fig. 6 ). In conclusion, analysis of histological stainings and preliminary scoring results indicated that C3 +/+ mice on a HFD display the highest hepatic lipid accumulation. Analysis of mRNA expression levels of lipid genes showed that adipose tissue expression levels of DGAT1
and HSL were higher in the C3 +/+ mice group, which corresponds with literature. The expression of the transcription factor PPARγ was higher in adipose tissue of mice fed a HFD, in agreement with the literature.
These data support a link between adipose tissue dysfunction and progression of hepatic steatosis, and the role of the enzymes HSL and DGAT herein.
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